These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6359172)

  • 1. Potential use of muramyl peptides in cancer therapy.
    Chedid LA
    Prog Clin Biol Res; 1983; 132E():261-71. PubMed ID: 6359172
    [No Abstract]   [Full Text] [Related]  

  • 2. The generation of tumoricidal activity in macrophages for the treatment of established metastases.
    Fidler IJ
    Symp Fundam Cancer Res; 1983; 36():421-35. PubMed ID: 6382518
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential therapeutic value of muramyl peptides for modulating human immunologic responses.
    Fogler WE
    Biotechnol Ther; 1989-1990; 1(1):69-83. PubMed ID: 2562645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
    Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
    J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope specific immunity elicited by totally synthetic monovalent or polyvalent vaccines.
    Chedid L; Audibert F; Jolivet M; Carelli C; Uzan M; Gras-Masse H; Tarter A
    Ann Sclavo Collana Monogr; 1984; 1(2):77-85. PubMed ID: 6400358
    [No Abstract]   [Full Text] [Related]  

  • 6. [Enhancement of resistance to microbial infection].
    Tamura M; Mameoka Y; Tsubura E
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Feb; 23(2):171-5. PubMed ID: 3839543
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulation of non-specific resistance and specific immune response against tumours in mice by synthetic muramyl dipeptide.
    Nĕmecková S; Bubeník J; Jezek J; Zaoral M
    Folia Biol (Praha); 1982; 28(5):327-33. PubMed ID: 7173449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of action and clinical effectiveness of immunomodulator glucosaminylmuramyl dipeptide (licopide)].
    Ivanov VT; Andronova TM; Nesmeianov VA; Pinegin BV; Ledger P; Bomford R; Khaitov RM
    Klin Med (Mosk); 1997; 75(3):11-5. PubMed ID: 9229604
    [No Abstract]   [Full Text] [Related]  

  • 9. [Augmentation of immune defense mechanisms of the lung by romurtide].
    Hasegawa J; Satoh A; Yagi K; Chida K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jun; 33(6):605-11. PubMed ID: 7666614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory activity of analog of muramyl dipeptide and their use as adjunct to chemotherapy of Leishmania donovani in hamster.
    Puri A; Sahai R; Haq W; Zaidi A; Guru PY; Tripathi LM; Srivastava VM
    Int Immunopharmacol; 2005 Jun; 5(6):937-46. PubMed ID: 15829410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of novel derivatives of muramyl dipeptide on the immune system].
    Kaliuzhin OV; Fuks BB; Bovin NV; Zemliakov AE; Chirva VIa
    Biull Eksp Biol Med; 1994 May; 117(5):510-3. PubMed ID: 9296705
    [No Abstract]   [Full Text] [Related]  

  • 12. Intracellular debugging.
    Kobayashi KS; Eynon EE; Flavell RA
    Nat Immunol; 2003 Jul; 4(7):652-4. PubMed ID: 12830145
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of pentadecapeptide mimicking muramyl peptide.
    Laman AG; Shepelyakovskaya AO; Berezin IA; Boziev KM; Rodionov IL; Chulina IA; Malakhova GV; Brovko FA; Murashev AN; Korpela TK; Nesmeyanov VA
    Vaccine; 2007 Apr; 25(15):2900-6. PubMed ID: 17005302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How far from a hormone-based contraceptive vaccine?
    Delves PJ
    J Reprod Immunol; 2004 Jun; 62(1-2):69-78. PubMed ID: 15288183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analogues of muramyl dipeptide (MDP) and tuftsin limit infection and inflammation in murine model of sepsis.
    Wardowska A; Dzierzbicka K; Szaryńska M; Dabrowska-Szponar M; Wiśniewska K; Myśliwski A; Trzonkowski P
    Vaccine; 2009 Jan; 27(3):369-74. PubMed ID: 19027810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in situ induction of tumoricidal activity in alveolar macrophages by liposomes containing muramyl dipeptide is a thymus-independent process.
    Fidler IJ
    J Immunol; 1981 Oct; 127(4):1719-20. PubMed ID: 6974201
    [No Abstract]   [Full Text] [Related]  

  • 17. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
    Fidler IJ; Schroit AJ
    J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and immunostimulating properties of lipophilic ester and ether muramyl peptide derivatives.
    Merhi G; Coleman AW; Devissaguet JP; Barratt GM
    J Med Chem; 1996 Oct; 39(22):4483-8. PubMed ID: 8893843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
    Reisser D; Jeannin JF; Martin F
    C R Seances Acad Sci III; 1982 Nov; 295(8):485-8. PubMed ID: 6819063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens.
    Yamamoto K; Kato K; Kakinuma M; Okuyama H; Azuma I
    Immunology; 1982 Jun; 46(2):473-9. PubMed ID: 7044961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.